4th ESPT Summer School: Precision Medicine and Personalised Health

Abstract

In September 2018, the European Society of Pharmacogenomics and Personalised Therapy (ESPT), with the support of the Swiss Personalized Health Network (SPHN), organized its 4th biennial summer school, entitled ‘Precision Medicine and Personalised Health’ (Campus Biotech, Geneva, Switzerland; www.esptsummerschool.eu/). The school’s comprehensive and innovative educational program aimed to address the fundamentals of pharmacogenomics, the latest knowledge on established and new concepts in the field of precision medicine, as well as its advanced clinical applications in personalized health. The school consisted of 31 lectures, eight interactive workshops, visits to genome center and poster presentations, involving 40 speakers from distinguished international faculties. The meeting was a resounding success by generating informal environments between more than 80 participants from 26 different countries.

Acknowledgments

The authors would like to thank the following people: ESPT Summer School chairs (M Ansari, P Meier-Abt), ESPT Education and Courses Division chairs (J Marc, VG Manolopoulos), ESPT board (RH van Schaik, VG Manolopoulos, S Stanković, I Cascorbi, M Ansari, P Jacobs, A Llerena, J Marc, M Simmaco, C Sipeky, S Visvikis-Siest), ESPT scientific committee (U Amstutz, M Ansari, M Dermitzakis, D Gunther, D Hochstrasser, VG Manolopoulos, J Marc, P Meier-Abt, UA Meyer, O Michielin, C Sipeky, D Trono, E Vayena), ESPT organising committee (A Lawrence, L Legros, L Selter, MS Ostan, M Tepernoux, M Festinase, B Zorzi), Swiss Group on Pharmacogenomics and Personalised Therapy (SPT) (P Meier-Abt, UA Meyer, U Amstutz, C Samer, P Baumann, R Bühlmann, Marc Ansari), session chairs, speakers and presenters.

Financial & competing interests disclosure

The organising committee would like to thank the following sponsors for their generous financial aid: The Bühlmann Laboratories AG, the CANSEARCH Foundartion, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), GenePredictis, Geneva University Hospitals (HUG), Strategic Focus Area: Personalised Health and Related Technologies, Swiss Academy of Medical Sciences (SAMW/ASSM), Sante Personnalisée and Société, Swiss Paediatrics Oncology Group (SPOG), Swiss Personalised Health Network (SPHN) and the University of Geneva. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

The organising committee would like to thank the following sponsors for their generous financial aid: The Bühlmann Laboratories AG, the CANSEARCH Foundartion, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), GenePredictis, Geneva University Hospitals (HUG), Strategic Focus Area: Personalised Health and Related Technologies, Swiss Academy of Medical Sciences (SAMW/ASSM), Sante Personnalisée and Société, Swiss Paediatrics Oncology Group (SPOG), Swiss Personalised Health Network (SPHN) and the University of Geneva. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.